Bacolod to have 5th lab for SARS Cov2 testing | Inquirer News
Close  

Bacolod to have 5th lab for SARS Cov2 testing

/ 07:42 PM November 23, 2020

BACOLOD CITY—Another laboratory would be added to the city’s capacity to test for SARS Cov2, the virus that causes COVID-19, and scale up efforts against the highly contagious disease.

The new lab is taking shape at Riverside Medical Center Inc. (RMCI) and was initially projected to have the capacity of 192 tests per day once it opens on Dec. 1, according to hospital director Ma. Antonia Gensoli.

ADVERTISEMENT

The tests will gradually build up to 300 per day, Gensoli said.

Dr. David Pedroza, head of the RMCI molecular biology section, said the laboratory will provide greater flexibility and space for added testing capacity as Bacolod City endures continued community transmission of SARS Cov2.

FEATURED STORIES

Results of tests at the RMCI laboratory are expected to be released in 24 to 72 hours.

“The laboratory strives to maintain and keep the facility and its equipment relevant across a variety of disciplines from infectious disease to oncology,” said Pedroza. Oncology is the study and treatment of tumors.

He said the new lab “will complement the growing demand for specialized testing.”

Aside from the one that would open in RMCI, four other labs are being operated in Bacolod for SARS Cov2 testing—the one in Corazon Locsin Montelibano Memorial Regional Hospital, one operated by the Philippine Red Cross, one in The Doctors’ Hospital and another one in Bacolod Queen of Mercy Hospital.

TSB

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: #COVID19PH, Bacolod City, Laboratory, Regions, testing
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.